Haemophagocytic lymphohistiocytosis (HLH) in an adult following treatment with trimethoprim/sulfamethoxazole
Authors:
Open Access
- 14 December 2022
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 15 (12) , e251255
Abstract
Haemophagocytic lymphohistiocytosis (HLH) is an aggressive hyperinflammatory haematological condition often associated with malignancy, infection or rheumatological disorders. HLH has rarely been associated with medications, including antibiotics. We describe a case of a patient without significant medical history who presented with HLH following treatment with trimethoprim/sulfamethoxazole (TMP/SMX). Additionally, we will discuss the possible mechanism of medication-induced HLH as well as the successful use of dexamethasone as the sole treatment. Early diagnosis and treatment of this disease is critical and medication-induced HLH should be considered in cases without a clear aetiology. To our knowledge, this is the first case report of TMP/SMX-induced HLH that was successfully treated with steroid monotherapy and just the second case report of TMP/SMX-induced HLH.Keywords
This publication has 18 references indexed in Scilit:
- 567: BACTRIM-INDUCED HYPERSENSITIVITY TRIGGERING HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSISCritical Care Medicine, 2018
- Severe hemophagocytic lymphohistiocytosis as a complication of drug-induced hypersensitivity syndromeInternational Journal of Critical Illness and Injury Science, 2015
- Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumabPediatric Blood & Cancer, 2012
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006
- Diagnosis and management of adult onset Still's diseaseAnnals of the Rheumatic Diseases, 2006
- drug-induced hemophagocytosisThe American Journal of Medicine, 2002
- Practical issues in the management of hypersensitivity reactions: sulfonamides.2001
- Practical Issues in the Management of Hypersensitivity ReactionsSouthern Medical Journal, 2001
- Trimethoprim‐sulphamethoxazole‐associated blood dyscrasias. Ten years'experience of the Swedish spontaneous reporting systemJournal of Internal Medicine, 1990
- Metabolite‐specific (IgG) and drug‐specific antibodies (IgG, IgM) in two cases of trimethoprim‐sulfamethoxazole‐induced immune thrombocytopeniaTransfusion, 1987